Increasing studies have demonstrated that H19 regulates canonical NF-κB signaling pathway activation in various types of human cancers, such as gastric cancer, thyroid cancer, melanoma, osteosarcoma, and multiple myeloma. The gene discussed is NFKB1; the disease is osteosarcoma.